News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioTime (BTIM.PK) Awarded a $4.7 Million Research Grant from the California Institute for Regenerative Medicine


4/30/2009 9:24:38 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc., (OTCBB:BTIM) announced today that the California Institute for Regenerative Medicine (CIRM) has approved a grant to the Company of $4.7 million to fund research related to its ACTCellerateâ„¢ embryonic stem cell technology. The overall objective of this grant is to generate tools useful in applying ACTCellerateâ„¢ technology to the manufacture of patient-specific therapeutic products.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES